Volume: 32 Issue: 3

1. Off-label use-the problem and challenge in clinical practice in China Page:193—195
2. Consideration of application of non-steroidal anti-inflammatory drugs in the treatment of allergic conjunctivitis Page:196—199
3. Inhibitory effect of rapamycin on the proliferation of Rhesus retinal vascular endothelial cells Page:216—219
4. Indocyanine green-assisted macular epiretinal membrane combined internal limiting membrane peeling for idiopathic macular epiretinal membrane Page:231—234
5. Regulating effect of aquaporin 4 gene on the expression of glial fibrillary acid protein in retina in chronic high intraocular pressure mice Page:241—245
6. The randomized controlled study on timolol preventing refractive regression after LASIK in high myopic eyes Page:257—261
7. Influential factors of blood glucose during perioperative period for patients with proliferative diabetic retinopathy Page:262—265
8. Comparison of the efficacy between cyclophotocoagulation and trabeculectomy for primary acute angle-closure glaucoma with persistent ocular hypertension Page:266—269
9. Current research of neuroprotective effect of chitosan Page:281—284
10. Establish of animal model of ocular ischemic syndrome Page:285—288
11. Pharmacokinetics characterization and toxicology of PNIPAAm-PEO nanoparticles loaded norvancomycin in rabbit eyes Page:200—205
12. Effects of CX3CL1 and CCL2 on the expressions of angiogenesis-related factors of human monocyte-derived macrophages Page:206—210
13. An updated view on dopamine in ophthalmology Page:278—280
14. Protection and mechanism of bushenhuoxue on retinal ganglian cells under the hypoxic condition in vitro Page:211—215
15. Protection of NEP1-40 on retinal cells following retinal ischemia reperfusion injury Page:220—225
16. Influence of triamcinolone acetonide on peribulbus tissues via periocular injection Page:226—230
17. Retrospective analysis of clinical features and management for drug-induced keratopathy Page:246—250
18. Comparison of clinical effects between bromfenac sodium versus glucocorticoid following LASIK Page:251—256
19. Research progress in chemokine receptor 3 and its ligands in ophthalmology Page:270—273
20. Application of anti-VEGF agents in the perioperative period of retinal vascular diseases Page:274—277